Switzerland-based Ascensia Diabetes Care has entered a global technology partnership with French firm Voluntis to optimise insulin management for patients suffering from type 2 diabetes.

Voluntis’ Insulia Diabetes Management Companion, a basal insulin management solution for type 2 diabetes, will be integrated with Ascensia’s Contour Next One and Contour Plus One blood glucose monitoring systems (BGMS).

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Based on diabetes-related data such as blood glucose values, Insulia provides insulin dose recommendations and educational coaching messages via a smartphone app.

The Contour systems feature a blood glucose smart metre that is connected to a mobile app called Contour Diabetes.

Through Bluetooth, the app collects, stores and analyses patient blood glucose measurements that are delivered by the metres.

“The simplicity and effectiveness of the Insulia solution combined with the remarkable accuracy of the Contour Next One and Contour Plus One blood glucose monitoring systems, has the ability to meaningfully impact the lives of people living with diabetes.”

Ascensia Diabetes Care CEO Michael Kloss said: “The simplicity and effectiveness of the Insulia solution combined with the remarkable accuracy of the Contour Next One and Contour Plus One blood glucose monitoring systems, has the ability to meaningfully impact the lives of people living with diabetes, and as a result, this could lead to better outcomes.”

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Basal insulin dosing for the patients will be calculated using the blood glucose readings obtained from the devices.

The primary objective of the integration is to enable self-management and insulin management optimisation for patients.

The connected solutions are expected to be available for diabetes patients and healthcare professionals in the fourth quarter of this year.

Ascensia has also signed a development agreement to connect its Contour Next One BGMS with Insulet’s Omnipod Dash System that is currently being developed to enable diabetes management.

Medical Device Network Excellence Awards - The Benefits of Entering

Gain the recognition you deserve! The Medical Device Network Excellence Awards celebrate innovation, leadership, and impact. By entering, you showcase your achievements, elevate your industry profile, and position yourself among top leaders driving medical devices advancements. Don’t miss your chance to stand out—submit your entry today!

Nominate Now